Marked urinary retention: Potentially misleading gynecologists into diagnosing the condition as a giant ovarian cyst.
Matsubara S.
J Obstet Gynaecol Res. 2023 Aug;49(8):2206-2207. doi: 10.1111/jog.15717. Epub 2023 Jun 8.
A 66-Year-Old Woman with Achondroplasia and Quadriparesis with an Ovarian Cyst Erroneously Diagnosed as Urinary Retention by an Automated Bladder Scan.
Chigrinskiy P, Heyman SN, Simons M, Pfeffer M, Marcus EL.
Am J Case Rep. 2022 Oct 27;23:e937318. doi: 10.12659/AJCR.937318.
PRMT5 Inhibitors Regulate DNA Damage Repair Pathways in Cancer Cells and Improve Response to PARP Inhibition and Chemotherapies.
Carter J, Hulse M, Sivakumar M, Burtell J, Thodima V, Wang M, Agarwal A, Vykuntam K, Spruance J, Bhagwat N, Rager J, Ruggeri B, Scherle P, Ito K.
Cancer Res Commun. 2023 Nov 6;3(11):2233-2243. doi: 10.1158/2767-9764.CRC-23-0070.
Lifestyle intervention in ovarian cancer enhanced survival (LIVES) study (NRG/GOG0225): Recruitment, retention and baseline characteristics of a randomized trial of diet and physical activity in ovarian cancer survivors.
Thomson CA, Crane TE, Miller A, Gold MA, Powell M, Bixel K, Van Le L, DiSilvestro P, Ratner E, Lele S, Guntupalli S, Huh W, Robertson SE, Modesitt S, Casey AC, Basen-Engquist K, Skiba M, Walker J, Kachnic L, Alberts DS.
Gynecol Oncol. 2023 Mar;170:11-18. doi: 10.1016/j.ygyno.2022.12.017. Epub 2023 Jan 4.
Ovarian mucinous cystadenoma causing acute urinary retention.
Pulvino JS, Resnick E, Wax JR.
J Clin Ultrasound. 2021 Jul;49(6):614-616. doi: 10.1002/jcu.22998. Epub 2021 Mar 4.
The splicing factor WBP11 mediates MCM7 intron retention to promote the malignant progression of ovarian cancer.
Wei Y, Chen Z, Li Y, Song K.
Oncogene. 2024 May;43(20):1565-1578. doi: 10.1038/s41388-024-03015-2. Epub 2024 Apr 1.
MEX3A promotes the malignant progression of ovarian cancer by regulating intron retention in TIMELESS.
Li F, Zhao C, Diao Y, Wang Z, Peng J, Yang N, Qiu C, Kong B, Li Y.
Cell Death Dis. 2022 Jun 17;13(6):553. doi: 10.1038/s41419-022-05000-7.
Salpingectomy as a means to reduce ovarian cancer risk.
Daly MB, Dresher CW, Yates MS, Jeter JM, Karlan BY, Alberts DS, Lu KH.
Cancer Prev Res (Phila). 2015 May;8(5):342-8. doi: 10.1158/1940-6207.CAPR-14-0293. Epub 2015 Jan 13.
CXCR6 by increasing retention of memory CD8(+) T cells in the ovarian tumor microenvironment promotes immunosurveillance and control of ovarian cancer.
Muthuswamy R, McGray AR, Battaglia S, He W, Miliotto A, Eppolito C, Matsuzaki J, Takemasa T, Koya R, Chodon T, Lichty BD, Shrikant P, Odunsi K.
J Immunother Cancer. 2021 Oct;9(10):e003329. doi: 10.1136/jitc-2021-003329.
Urinary retention due to ovarian cyst.
Kingsnorth AN.
Br J Urol. 1984 Aug;56(4):439-40. doi: 10.1111/j.1464-410x.1984.tb05845.x.
